Historical Stock Price
BPTH historical stock prices picture
Bio-Path Holdings (BPTH) has the following price history information. Looking back at BPTH historical stock prices for the last five trading days, on April 19, 2024, BPTH opened at $4.25, traded as high as $4.57 and as low as $3.80, and closed at $4.29. Trading volume was a total of 2.15M shares. On April 22, 2024, BPTH opened at $3.85, traded as high as $3.95 and as low as $2.85, and closed at $2.92. Trading volume was a total of 869.60K shares. On April 23, 2024, BPTH opened at $2.81, traded as high as $2.85 and as low as $2.60, and closed at $2.69. Trading volume was a total of 321.10K shares. On April 24, 2024, BPTH opened at $2.65, traded as high as $2.79 and as low as $2.46, and closed at $2.49. Trading volume was a total of 165.00K shares. On April 25, 2024, BPTH opened at $2.49, traded as high as $2.75 and as low as $2.35, and closed at $2.64. Trading volume was a total of 155.90K shares.

BPTH Historical Stock Prices By Date:

BPTH historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Path Holdings shares, starting with a $10,000 purchase of BPTH, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/29/2014
End date: 04/25/2024
Start price/share: $9,320.00
End price/share: $2.64
Dividends collected/share: $0.00
Total return: -99.97%
Average Annual Total Return: -55.83%
Starting investment: $10,000.00
Ending investment: $2.83
Years: 10.00
Date Open High Low Close Volume
04/19/2024 $4.25 $4.57 $3.80 $4.29 2.15M
04/22/2024 $3.85 $3.95 $2.85 $2.92 869.60K
04/23/2024 $2.81 $2.85 $2.60 $2.69 321.10K
04/24/2024 $2.65 $2.79 $2.46 $2.49 165.00K
04/25/2024 $2.49 $2.75 $2.35 $2.64 155.90K
Bio-Path Holdings is a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company utilizing a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s primary drug candidate, prexigebersen, which targets growth factor receptor-bound protein 2, initially started the efficacy portion of a Phase 2 clinical trial for untreated acute myeloid leukemia patients. Co.'s second drug candidate, Liposomal Bcl-2, targets the protein Bcl-2, which is responsible for driving cell survival in up to 60% of all cancers. Co.'s third drug candidate, Liposomal STAT3, targets the STAT3 protein.
Date Close
04/19/2024$4.29
04/22/2024$2.92
04/23/2024$2.69
04/24/2024$2.49
04/25/2024$2.64
BPTH is categorized under the Healthcare sector; below are some other companies in the same sector:

BRKR Historical Stock Prices
BRLI Historical Stock Prices
BSDM Historical Stock Prices
BSPM Historical Stock Prices
BSTC Historical Stock Prices
BSTG Historical Stock Prices
BSX Historical Stock Prices
BTI Historical Stock Prices
BTX Historical Stock Prices
BUG Historical Stock Prices

Also explore: BPTH shares outstanding history

Email EnvelopeFree BPTH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


BPTH Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.